Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 625.00 | 320.09 | 804.00 | 794.00 | 1.0126 | 1.0192 |
| BT-20 | Linsitinib | 1 | uM | 9 | 625.00 | 320.09 | 743.00 | 794.00 | 0.9358 | 0.9012 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 718.00 | 794.00 | 0.9043 | 0.8522 | |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 639.00 | 794.00 | 0.8048 | 0.6946 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 625.00 | 320.09 | 401.00 | 794.00 | 0.5050 | 0.1876 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 687.00 | 794.00 | 0.8652 | 0.7909 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 986.00 | 794.00 | 1.2418 | 1.3594 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 906.00 | 794.00 | 1.1411 | 1.2118 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 625.00 | 320.09 | 1009.00 | 794.00 | 1.2708 | 1.4012 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 625.00 | 320.09 | 965.00 | 794.00 | 1.2154 | 1.3209 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 1104.00 | 794.00 | 1.3904 | 1.5719 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 625.00 | 320.09 | 1026.00 | 794.00 | 1.2922 | 1.4320 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 1039.00 | 794.00 | 1.3086 | 1.4555 | |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 625.00 | 320.09 | 903.00 | 794.00 | 1.1373 | 1.2063 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 625.00 | 320.09 | 296.00 | 794.00 | 0.3728 | -0.0580 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 625.00 | 320.09 | 985.00 | 794.00 | 1.2406 | 1.3575 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 1075.00 | 794.00 | 1.3539 | 1.5202 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 625.00 | 320.09 | 285.00 | 794.00 | 0.3589 | -0.0848 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 625.00 | 320.09 | 1004.00 | 794.00 | 1.2645 | 1.3921 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 989.00 | 794.00 | 1.2456 | 1.3648 | |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 625.00 | 320.09 | 913.00 | 794.00 | 1.1499 | 1.2249 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 971.00 | 794.00 | 1.2229 | 1.3319 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 625.00 | 320.09 | 894.00 | 794.00 | 1.1259 | 1.1895 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 625.00 | 320.09 | 330.00 | 794.00 | 0.4156 | 0.0235 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 656.00 | 794.00 | 0.8262 | 0.7289 |